30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Comera Life Sciences Holdings Inc (CMRA)

Track

Stock chart
Ticker: CMRA Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Campbell Michael Gerard
EVP & CFO
1 purchase — total 708 USD
Buy 27 Nov 2023
Value US$3,833,221.75 | Price 358.07 | Shares 18,386
Buy 11 Sep 2023
Value US$4,010,912.02 | Price 354.70 | Shares 58,079
Buy 11 Sep 2023
Value US$1,904,883.24 | Price 14.73 | Shares 98,518
Buy 11 Sep 2023
Value US$1,049,896.94 | Price 0.51 | Shares 2,053,789
Buy 14 Aug 2023
Value US$12,504.00 | Price 0.63 | Shares 20,000
Buy 31 Jul 2023
Value US$450,043.70 | Price 0.51 | Shares 880,195
Buy 31 Jul 2023
Value US$69,992.99 | Price 0.51 | Shares 136,919
Buy 31 Jul 2023
Value US$69,992.99 | Price 0.51 | Shares 136,919
Buy 4 Jan 2023
Value US$914,188.89 | Price 1.23 | Shares 743,243
Buy 4 Jan 2023
Value US$83,107.41 | Price 1.23 | Shares 67,567
Buy 4 Jan 2023
Value US$83,107.41 | Price 1.23 | Shares 67,567
Buy 4 Jan 2023
Value US$83,107.41 | Price 1.23 | Shares 67,567
Buy 8 Nov 2022
Value US$4,147.80 | Price 1.38 | Shares 3,000
Buy 21 Oct 2022
Value US$18,631.95 | Price 1.59 | Shares 11,691
Buy 20 Oct 2022
Value US$5,048.28 | Price 1.52 | Shares 3,316
Buy 17 Oct 2022
Value US$25,344.61 | Price 1.66 | Shares 15,266
Buy 14 Oct 2022
Value US$6,822.66 | Price 1.60 | Shares 4,253
Buy 13 Oct 2022
Value US$17,386.93 | Price 1.66 | Shares 10,481
Buy 27 Sep 2022
Value US$20,221.20 | Price 1.69 | Shares 12,000
Buy 12 Sep 2022
Value US$101,500.00 | Price 2.03 | Shares 50,000
Buy 9 Sep 2022
Value US$98,056.00 | Price 2.06 | Shares 47,600
Buy 8 Sep 2022
Value US$51,750.00 | Price 2.07 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-28 2023-11-27 B Purchase
1.1
Campbell Michael Gerard

EVP & CFO

Officer
18,386 -42.7%
358.07
US$3,833,222 		18,386 -42.7% 358.07 US$3,833,222
2023-09-12 2023-09-11 B Purchase
1.7
Soane David
Large shareholder
58,079 -25.5%
354.70
US$4,010,912 		58,079 -25.5% 354.70 US$4,010,912
2023-09-12 2023-09-11 B Purchase
1.7
Soane David
Large shareholder
98,518 -28.1%
14.73
US$1,904,883 		98,518 -28.1% 14.73 US$1,904,883
2023-09-11 2023-09-11 B Purchase
3.9
Cherington Charles
Large shareholder
2,053,789 +54.6%
0.51
US$1,049,897 		2,053,789 +54.6% 0.51 US$1,049,897
2023-08-15 2023-08-14 B Purchase
0.5
Mahoney Robert Patrick

Chief Scientific Officer

Officer
20,000 +19.1%
0.63
US$12,504 		20,000 +19.1% 0.63 US$12,504
2023-08-25 2023-07-31 B Purchase
3.9
Cherington Charles
Large shareholder
880,195 +30.6%
0.51
US$450,044 		880,195 +30.6% 0.51 US$450,044
2023-08-02 2023-07-31 B Purchase
1.7
Soane David
Large shareholder
136,919 +154.3%
0.51
US$69,993 		136,919 +154.3% 0.51 US$69,993
2023-08-02 2023-07-31 B Purchase
1.7
Soane David
Large shareholder
136,919 +154.3%
0.51
US$69,993 		136,919 +154.3% 0.51 US$69,993
2023-01-06 2023-01-04 B Purchase
3.9
Cherington Charles
Large shareholder
743,243 +34.8%
1.23
US$914,189 		743,243 +34.8% 1.23 US$914,189
2023-01-06 2023-01-04 B Purchase
1.7
Soane David
Large shareholder
67,567 +319.3%
1.23
US$83,107 		67,567 +319.3% 1.23 US$83,107
2023-01-06 2023-01-04 B Purchase
1.7
Soane David
Large shareholder
67,567 +319.3%
1.23
US$83,107 		67,567 +319.3% 1.23 US$83,107
2023-01-06 2023-01-04 B Purchase
1.7
Soane David
Large shareholder
67,567 +2.1%
1.23
US$83,107 		67,567 +2.1% 1.23 US$83,107
2022-11-09 2022-11-08 B Purchase
1.7
Soane David
Large shareholder
3,000 +0.1%
1.38
US$4,148 		3,000 +0.1% 1.38 US$4,148
2022-10-24 2022-10-21 B Purchase
3.9
Cherington Charles
Large shareholder
11,691 +1.8%
1.59
US$18,632 		11,691 +1.8% 1.59 US$18,632
2022-10-24 2022-10-20 B Purchase
3.9
Cherington Charles
Large shareholder
3,316 +0.5%
1.52
US$5,048 		3,316 +0.5% 1.52 US$5,048
2022-10-18 2022-10-17 B Purchase
3.9
Cherington Charles
Large shareholder
15,266 +2.5%
1.66
US$25,345 		15,266 +2.5% 1.66 US$25,345
2022-10-18 2022-10-14 B Purchase
3.9
Cherington Charles
Large shareholder
4,253 +0.7%
1.60
US$6,823 		4,253 +0.7% 1.60 US$6,823
2022-10-14 2022-10-13 B Purchase
3.9
Cherington Charles
Large shareholder
10,481 +1.7%
1.66
US$17,387 		10,481 +1.7% 1.66 US$17,387
2022-09-29 2022-09-27 B Purchase
3.9
Cherington Charles
Large shareholder
12,000 +2.1%
1.69
US$20,221 		12,000 +2.1% 1.69 US$20,221
2022-09-12 2022-09-12 B Purchase
0.6
Sherblom James
Non-Executive Director
50,000 +15.6%
2.03
US$101,500 		50,000 +15.6% 2.03 US$101,500
2022-09-12 2022-09-09 B Purchase
2.5
Hackman Jeffrey S.

See Remarks

Executive Director
47,600 +inf%
2.06
US$98,056 		47,600 +inf% 2.06 US$98,056
2022-09-12 2022-09-08 B Purchase
1.1
Campbell Michael Gerard

EVP & CFO

Officer
25,000 +inf%
2.07
US$51,750 		25,000 +inf% 2.07 US$51,750
Explore more

More insider trading research around Comera Life Sciences Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America